Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by IainCaimbeulon Feb 02, 2024 3:31pm
91 Views
Post# 35860237

RE:RE:RE:RE:RE:WHO says:1 in 5 will get cancer in their lifetime

RE:RE:RE:RE:RE:WHO says:1 in 5 will get cancer in their lifetimeNo, I don't mean SAB, that is just more rubbish, another Dog and Pony show, three members, one PHD. Gee maybe I could buy a good book on nutrition that would make things way better. Let me know exactly what SAB has added to the bottom line of Stagezero?

SAB's are just another way to reward your buddies. Ever heard of Meta Materialss (MMAT) out of Dartmouth NS? They have that SAB tripe comming out of their ears, but they CANNOT bring anything to market and make money. In the last 2 years they have gone from approximately $5.75 USD to 4 CENTS. They just did a reverse split of 100:1. Fortunately I dumped this DOG (small holding) couple of years ago. THIS is what is coming for Stagezero.
Nailbiter2 wrote: You mean our SAB?

StageZero Scientific Advisory Board - StageZero Life Sciences

IainCaimbeul wrote: Same old 4 directors on the board. What happened to the board member from Care? Probably quit or was fired by Tripp. Thoughts?
Liked2Think wrote:

Colonsentry was a scam and all they did is come up with a new name for the same results. 

covid happened and gave them the ability to buy another company in Care. They are slowly destroying all value from Care. 

I give them 4-5 years of Tripp still getting paid while revenue goes down and down and down. Reverse split and continuing until bankrupt but down worry Tripp will get a nice severance package with the last of the money left

 







<< Previous
Bullboard Posts
Next >>